New hope for Alzheimer's? phase 3 trial of DMB-I begins
NCT ID NCT07251023
First seen Jun 27, 2026 ยท Last updated Jun 27, 2026
Summary
This study tests whether the drug DMB-I (latrepirdine) can improve thinking and memory in people with mild to moderate Alzheimer's dementia. About 450 adults aged 60-90 will take either DMB-I, a placebo, or an active comparator for 26 weeks. Researchers will compare changes in cognitive test scores and monitor for side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER TYPE DEMENTIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
"Medical Center Nova Vita" LLC
RECRUITINGRostov-on-Don, 344082, Russia
-
"Medical services" LLC
RECRUITINGSaint Petersburg, 194356, Russia
-
"Sphera Med" LLC
RECRUITINGSaint Petersburg, 197342, Russia
-
Federal State Autonomous Educational Institution of Higher Education I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University)
RECRUITINGMoscow, 119991, Russia
-
Federal State Budgetary Institution "Federal Center for Brain and Neurotechnology" of the Federal Medical and Biological Agency
RECRUITINGMoscow, 117513, Russia
-
Moscow State budgetary healthcare institution "City Clinical Hospital named after V.M. Buyanov of the Moscow Healthcare Department"
RECRUITINGMoscow, 115516, Russia
-
Nizhny Novgorod region State budgetary healthcare institution " Nizhny Novgorod Clinical Psychiatric Hospital No. 1"
RECRUITINGNizhny Novgorod, 603155, Russia
-
Saint Petersburg State budgetary healthcare institution "City Hospital No. 40 of Kurortniy district"
RECRUITINGSaint Petersburg, 197706, Russia
-
Saint Petersburg State budgetary healthcare institution "Psychiatric Hospital No. 1 named after P.P. Kashchenko"
RECRUITINGSaint Petersburg, 188357, Russia
-
Saint Petersburg State budgetary healthcare institution "Psychoneurologic dispensary โ 5"
RECRUITINGSaint Petersburg, 195176, Russia
-
State autonomous healthcare institution "Transregional Clinical Diagnostic Center"
RECRUITINGKazan', 420101, Russia
-
State budgetary healthcare institution "Leningrad Regional Mental Health Center"
RECRUITINGRoshchino, 188820, Russia
More trials for these conditions
Other studies related to the condition(s) this trial covers.